Security Snapshot

Acutus Medical, Inc. - Common Stock, par value $0.001 per share (AFIB) Institutional Ownership

CUSIP: 005111109

13F Institutional Holders and Ownership History from Q3 2020 to Q3 2025

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

$0.05

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Shares outstanding
60,359,615
SEC-reported price per share
$0.05
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • AFIB - Acutus Medical, Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 005111109.
  • Latest finished 13F holder period is not available.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 1 to 0 between Q2 2025 and Q3 2025.
  • SEC-reported value moved from $4 to $0.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

005111109

Latest holder period

n/a

13F holders

13D/G owners

1

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
1
Security
AFIB
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Flynn James E 9.1% 0% $233,441 -$179,058 5,492,725 -43% James E. Flynn 27 Jan 2025

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
21
Latest
n/a
Rows shown
1-21 of 21
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 0 $0 -$4 $0.05 0
2025 Q2 2,000 $4 $0.00 1
2025 Q1 2,000 $85 -$43 $0.04 1
2024 Q4 3,000 $165 $0.06 1
2024 Q3 3,000 $252 -$286 $0.08 1
2024 Q2 6,400 $227 -$1,237,360 $0.04 1
2024 Q1 6,592,463 $1,238,563 -$76,859 $0.19 21
2023 Q4 6,995,274 $1,411,110 -$885,030 $0.20 27
2023 Q3 8,589,440 $5,982,496 -$427,073 $0.70 28
2023 Q2 9,152,813 $8,125,423 -$39,586 $0.89 34
2023 Q1 9,230,428 $6,957,352 -$337,566 $0.75 37
2022 Q4 9,249,623 $10,637,045 -$1,090,548 $1.15 35
2022 Q3 10,327,199 $9,087,000 -$958,274 $0.88 30
2022 Q2 11,180,047 $12,516,000 -$5,242,416 $1.12 41
2022 Q1 15,930,046 $22,142,780 -$3,508,681 $1.39 59
2021 Q4 17,800,805 $60,690,000 -$44,289,931 $3.41 67
2021 Q3 20,249,026 $179,069,000 -$37,260,622 $8.84 66
2021 Q2 23,181,575 $393,897,000 +$10,530,619 $16.98 64
2021 Q1 22,813,007 $304,806,000 -$12,262,255 $13.37 65
2020 Q4 20,785,062 $598,581,348 +$43,795,744 $28.81 63
2020 Q3 19,216,927 $572,658,314 +$572,658,314 $29.80 68
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .